Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2010

Open Access 01-12-2010 | Research

Content comparison of haemophilia specific patient-rated outcome measures with the international classification of functioning, disability and health (ICF, ICF-CY)

Authors: Silvia Riva, Monika Bullinger, Edda Amann, Sylvia von Mackensen

Published in: Health and Quality of Life Outcomes | Issue 1/2010

Login to get access

Abstract

Background

Patient-Reported Outcomes (PROs) are considered important outcomes because they reflect the patient's experience in clinical trials. PROs have been included in the field of haemophilia only recently.

Purpose

Comparing the contents of PROs measures used in haemophilia, based on the ICF/ICF-CY as frame of reference.

Methods

Haemophilia-specific PROs for adults and children were selected on the grounds of international accessibility. The content of the selected instruments were examined by linking the concepts within the items of these instruments to the ICF/ICF-CY.

Results

Within the 5 selected instruments 365 concepts were identified, of which 283 concepts were linked to the ICF/ICF CY and mapped into 70 different categories. The most frequently used categories were "b152: Emotional functions" and "e1101: Drugs".

Conclusions

The present paper provides an overview on current PROs in haemophilia and facilitates the selection of appropriate instruments for specific purposes in clinical and research settings. This work was made possible by the grant of the European Murinet Project (Multidisciplinary Research Network on Health and Disability in Europe).
Appendix
Available only for authorised users
Literature
1.
2.
White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J: Factor VIII and Factor IX Subcommittee. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis 2001, 85: 560.
3.
Kern M, Blanchette V, Stain AM, Einarson TR, Feldman BM: Clinical and cost implications of target joints in Canadian boys with severe hemophilia. Am J Pediatr 2004,145(5):628–634. 10.1016/j.jpeds.2004.06.082CrossRef
4.
Mulder K, Llinás A: The target joint. Haemophilia 2004,10(4):152–156. 10.1111/j.1365-2516.2004.00976.xPubMedCrossRef
5.
Mannucci PM: Hemophilia: treatment options in the twenty-first century. Journal of Thrombosis and Haemostasis 1: 1349–1355. 10.1046/j.1538-7836.2003.00262.x
6.
Ljung R: Second Workshop of the European Paediatric Network for Haemophilia Management, 17–19 September 1998 in Vitznau/Switzerland. Haemophilia 1999,5(4):286–291. 10.1046/j.1365-2516.1999.00328.xPubMedCrossRef
7.
Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C: Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia 2003,9(1):1–4. 10.1046/j.1365-2516.9.s1.17.xPubMedCrossRef
8.
Hay CH: Prophylaxis in adults with haemophilia. Haemophilia 2007,13(2):10–5. 10.1111/j.1365-2516.2007.01500.xPubMedCrossRef
9.
Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA: Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999, 5: 378–385. 10.1046/j.1365-2516.1999.00347.xPubMedCrossRef
10.
Fischer K, Van der Bom JG, Van den Berg HM: Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia 2003,9(1):75–82. 10.1046/j.1365-2516.9.s1.13.xPubMedCrossRef
11.
Scalone L, Mantovani LG, Mannucci PM, Gringeri A: The COCIS Study Investigators. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia 2006,12(2):154–162. 10.1111/j.1365-2516.2006.01204.xPubMedCrossRef
12.
Gringeri A, Mantovani LG, Scalone L, Mannucci PM, the COCIS Study Group: Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003,102(7):2358–2363. 10.1182/blood-2003-03-0941PubMedCrossRef
13.
Beeton K: Evaluation of outcome of care in patients with haemophilia. Haemophilia 2002,8(3):428–434. 10.1046/j.1365-2516.2002.00599.xPubMedCrossRef
14.
Gringeri A, Mantovani L, von Mackensen S: Quality of life assessment in clinical practice in haemophilia treatment. Haemophilia 2006,12(3):1–8. 10.1111/j.1365-2516.2006.01257.x
15.
Marshall S, Haywood K, Fitzpatrick R: Impact of patient-reported outcome measures on routine practice: a structured review. Journal of Evaluation in Clinical Practice 2005,12(5):559–568. 10.1111/j.1365-2753.2006.00650.xCrossRef
16.
Revicki DA, Gnanasakthy A, Weinfurt K: Documenting the rationale and psychometric characteristics of patient reported outcomes for labelling and promotional claims: the PRO evidence dossier. Quality of Life Research 2007,16(7):17–23.
17.
Bullinger M, Globe D, Wasserman J, Young NL, von Mackensen S, on behalf of the Health Related: Quality of Life Expert Working Group of the International Prophylaxis Study Group (IPSG). Challenges of Patient-Reported Outcome Assessment in Haemophilia Care - a State of the Art Review. Value and Health 2009,12(5):808–820. 10.1111/j.1524-4733.2009.00523.xCrossRef
18.
Cella DF, Tulsky DS: Measuring Quality of Life Today: Methodological Aspects. Oncology 1990,4(5):29–38.PubMed
19.
Bullinger M: Quality of life - definition, conceptualization and implications. A methodologists view. Theoretical Surgery 1991, 6: 143–148.
20.
Bullinger M, von Mackensen S, Fischer K, Khair K, Petersen C, Ravens-Sieberer U, Rocino A, Sagnier P, Tusell JM, van den Berg M, Vicariot M: Pilot testing of the Haemo-QoL quality of life questionnaire for haemophiliac children in six European countries. Haemophilia 2002,8(2):47–54. 10.1046/j.1351-8216.2001.114.doc.xPubMedCrossRef
21.
von Mackensen S, Bullinger M, the Haemo-QoL Group: Development and testing of an instrument to assess the quality of life of children with haemophilia in Europe (Haemo-QoL). Haemophilia 2004,10(Suppl. 1):17–25. 10.1111/j.1355-0691.2004.00875.xPubMedCrossRef
22.
Young N, Bradley C, Blanchette V, Wakefield C, Barnard D, McCusker P: Development of a health-related quality of life measure for boys with haemophilia: The Canadian Haemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT). Haemophilia 2004,10(Suppl.1):34–43. 10.1111/j.1355-0691.2004.00877.xPubMedCrossRef
23.
Manco-Johnson M, Morrissey-Harding G, Edelman-Lewis B, Oster G, Larson P: Development and validation of a measure of disease-specific quality of life in young children with haemophilia. Haemophilia 2004, 10: 34–41. 10.1046/j.1365-2516.2003.00842.xPubMedCrossRef
24.
Arranz P, Remor E, Quintana M, Villar A, Díaz JL, Moreno M, Monteagudo J, Ugarriza A, Soto I, Pérez R, Chacón J, García-Luaces M, Cid A, Balda I, López MF, Gutíerrez MJ, Martínez E, Marrero C, Prieto M, Sedano C, Vaca R, Altisent C, Hernández-Navarro F, Hemofilia-QoL Group: Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia. Haemophilia 2004,10(4):376–82. 10.1111/j.1365-2516.2004.00918.xPubMedCrossRef
25.
Rentz A, Flood E, Altisent C, Bullinger M, Klamroth R, Garrido PR, Scharrer I, Schramm W, Gorina E, the members of the Steering committee of Haemo-Qol-A: Cross-cultural development and psychometric evaluation of patient-reported health-related quality of life questionnaire for adults with haemophilia. Haemophilia 2008, 14: 1023–1030. 10.1111/j.1365-2516.2008.01812.xPubMedCrossRef
26.
von Mackensen S, Gringeri A, Ravera S, the HAEM-A-QoL Group: Validation of the haemophilia-specific quality of life questionnaire for adult patients with haemophilia (Haem-A-QoL). Haematologica 2005,90(Suppl. 2):115–116.
27.
von Mackensen S, Gringeri A: Quality of Life in Hemophilia. In Handbook of Disease Burdens and Quality of Life Measure. Edited by: Preedy VR, Watson RR. Springer, Heidelberg; 2010:4500. Chapter 215, Version: *eReference* (online access)
28.
Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M: Issues in the management of satisfaction with treatment. American Journal of Managed Care 1997, 3: 579–594.PubMed
29.
Revicki DA: Patient assessment of treatment satisfaction: methods and practical issues. GUT 2004,53(4):40–44. 10.1136/gut.2003.034322
30.
von Mackensen S, Gringeri A, Mantovani L, et al.: Development and validation of the first treatment satisfaction scale for adult haemophiliacs (Hemo-Sat A ). Haemophilia 2004,10(Suppl. 3):126. abstract
31.
Van Genderen FR, Van Meeteren NLU, Van der Bom JG: Functional consequences of haemophilia in adults: the development of the haemophilia activities list. Haemophilia 2004, 10: 565–571. 10.1111/j.1365-2516.2004.01016.xPubMedCrossRef
32.
von Mackensen S, Czepa D, Herbsleb M, Hilberg T: Development and validation of a new questionnaire for the assessment of subjective physical performance in adult patients with haemophilia--the HEP-Test-Q. Haemophilia 2010,16(1):170–8. Epub 2009 Oct 21 10.1111/j.1365-2516.2009.02112.xPubMedCrossRef
33.
Cieza A, Brockow T, Ewert T, Amman E, Stucki G: Linking health-status measurements to the international classification of functioning, disability and health. Journal of Rehabilitation Medicine 2002, 34: 205–210. 10.1080/165019702760279189PubMedCrossRef
34.
35.
World Health Organization: International classification of functioning, disability and health. ICF. In World Health Organization. Geneva; 2001.
36.
World Health Organization: International classification of impairments, disabilities and handicapps. In World Health Organization. Geneva; 2001.
37.
Simeonsson RJ, Hollenweger J, Lollar D, Martinuzzi A, Leonardi M, Bjorck-Akesson E: Applying the International Classification of Functioning, Disability and Health (ICF) to measure childhood disability. Disability and Rehabiitationl 2003,3(17;25):602–610. 10.1080/0963828031000137117CrossRef
38.
Lollar DJ, Simeonsson RJ: Diagnosis to function: classification for children and youths. Developmental and Behavioral Pediatrics 2005, 26: 323–330. 10.1097/00004703-200508000-00012CrossRef
39.
World Health Organization: International classification of functioning, disability, and health. Children and Youth Version ICF-CY. In World Health Organization. Switzerland, Geneva; 2007.
40.
Simeonson RJ, Lollar DJ, Hollowell J, Adams M: Revision of the international classification of impairments, disabilities and handicaps: developmental issues. Journal of Clinical Epidemiology 2000, 53: 113–124. 10.1016/S0895-4356(99)00133-XCrossRef
41.
Ustun TB, Chatterji S, Bickenbach J, Kostanjsek N, Schneider M: The international classification of functioning, disability and health: A new tool for understanding disability and health. Disability and Rehabilitation 2003,25(11):565–571. 10.1080/0963828031000137063PubMedCrossRef
42.
Khan F, Pallant J: Use of international classification of functioning, disabilityAnd health (icf) to describe patient-reported disability in multiple sclerosis and identification of relevant environmental factors. Journal of Rehabilitation Medicine 2007, 39: 63–70. 10.2340/16501977-0002PubMedCrossRef
43.
Cieza A, Stucki G: Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Quality of Life Research 2005, 14: 1225–1237. 10.1007/s11136-004-4773-0PubMedCrossRef
44.
45.
von Mackensen S, Scalone L, Ravera S, Mantovani L, Gringeri A, the COCHE Study Group: Assessment of health-related quality of life in patients with haemophilia with the newly developed haemophilia-specific instrument (Haem-A-QoL). Value and Health 2005, 8: A127.CrossRef
46.
47.
Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B, Stucki G: ICF linking rules: an update based on lessons learned. Journal of Rehabilitation Medicine 2005,37(2):212–218. 10.1080/16501970510040263PubMedCrossRef
48.
Cohen J: A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960, 20: 37–46. 10.1177/001316446002000104CrossRef
49.
50.
Vestling M, Tufvesson B, Iwarsson S: Indicators for return to work after stroke and the importance of work for subjective well-being and life satisfaction. Journal of Rehabilitation Medicine 2003,35(3):127–131. 10.1080/16501970310010475PubMedCrossRef
51.
Gringeri A, von Mackensen S, Auerswald G, Bullinger M, Perrez garrido R, Kellermann E, Khair K, Lenk H, Vicario M, Villar S, Wermes C: Health status and health-related quality of life of children with haemophilia from six European countries. Haemophilia 2004,10(suppl.1):26–33. 10.1111/j.1355-0691.2004.00876.xPubMedCrossRef
52.
Simeonsson RJ, Scarborough A, Hebbeler K: ICF and ICD codes provide a standard language of disability in young children. Journal of Clinical Epidemiology 2006, 59: 365–373. 10.1016/j.jclinepi.2005.09.009PubMedCrossRef
53.
Metadata
Title
Content comparison of haemophilia specific patient-rated outcome measures with the international classification of functioning, disability and health (ICF, ICF-CY)
Authors
Silvia Riva
Monika Bullinger
Edda Amann
Sylvia von Mackensen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2010
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-8-139

Other articles of this Issue 1/2010

Health and Quality of Life Outcomes 1/2010 Go to the issue

Review

Type D personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems

Research

Validation of a core outcome measure for palliative care in Africa: the APCA African Palliative Outcome Scale

Research

Health related quality of life after extremely preterm birth: a matched controlled cohort study

Research

How do children at special schools and their parents perceive their HRQoL compared to children at open schools?

Research

Experiences and barriers to Health-Related Quality of Life following liver transplantation: a qualitative analysis of the perspectives of pediatric patients and their parents

Research

Validation of a computer-adaptive test to evaluate generic health-related quality of life